Ultrastructural and histochemical markers of endometrial secretion induction in habitual miscarriage.
Biphasic hormone therapy at the stage of pre-gestation treatment of patients with habitual miscarriages stimulates the expression of progesterone receptors in the endometrium during the secretory phase of the menstrual cycle with full-value ultrastructural rearrangement of the endometrial glandular components in comparison with the patients receiving metabolic therapy alone.
Ilizarova
N A
NA
Institute of Regional Pathology and Pathomorphology, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia. pathol@soramn.ru
Marinkin
I O
IO
Ageeva
T A
TA
Bgatova
N P
NP
Kuleshov
V M
VM
Aidagulova
S V
SV
D000022:Abortion, Spontaneous / Q000097:blood / Q000188:drug therapy / Q000473:pathology; D000328:Adult; D015415:Biomarkers / Q000378:metabolism*; D004717:Endometrium / Q000378:metabolism / Q000648:ultrastructure; D004958:Estradiol / Q000097:blood; D015914:Estrogen Replacement Therapy; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008597:Menstrual Cycle; D011247:Pregnancy; D011374:Progesterone / Q000097:blood; D011980:Receptors, Progesterone / Q000378:metabolism
D015415:Biomarkers; D011980:Receptors, Progesterone; D011374:Progesterone; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone